Francesco Barilla
Overview
Explore the profile of Francesco Barilla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
819
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rebecchi M, De Ruvo E, Sette A, Grieco D, De Luca L, Strano S, et al.
Eur Heart J Suppl
. 2025 Feb;
27(Suppl 1):i171-i176.
PMID: 39980791
Cardioneuroablation (CNA) is now recognized as a safe and effective method in patients with cardioinhibitory neurocardiogenic syncope (CNCS), especially in young patients in order to avoid or prolong, as much...
2.
Belli M, Margonato D, Prandi F, Barone L, Muscoli S, Lecis D, et al.
J Cardiovasc Med (Hagerstown)
. 2025 Jan;
26(2):88-101.
PMID: 39841914
Atrial cardiomyopathy (AC) has been defined by the European Heart Rhythm Association as "Any complex of structural, architectural, contractile, or electrophysiologic changes in the atria with the potential to produce...
3.
Mattioli A, Coppi F, Severino P, Penna C, Pagliaro P, Dei Cas A, et al.
Nutrients
. 2025 Jan;
17(1.
PMID: 39796548
Vitamin D is increasingly recognized for its role in cardiovascular health beyond its well-established effects on bone metabolism. This review synthesizes findings from observational studies, interventional trials, and meta-analyses to...
4.
Palazzuoli A, Pirrotta F, Cartocci A, Delcuratolo E, Dini F, Correale M, et al.
Ther Adv Cardiovasc Dis
. 2024 Nov;
18:17539447241285136.
PMID: 39611607
Background: Sacubitril/valsartan (S/V) is a cornerstone treatment for heart failure (HF). Beneficial effects on hospitalization rates, mortality, and left ventricular remodeling have been observed in patients with heart failure and...
5.
Paolillo S, Graziani M, Indolfi C, Zaninotto M, Calabro P, Ceriotti F, et al.
G Ital Cardiol (Rome)
. 2024 Sep;
25(10):756-762.
PMID: 39342561
Dyslipidemia is one of the most important risk factors for the development of atherosclerotic disease and its control, through well-proven therapies, allows an optimal risk management over time. LDL-cholesterol targets...
6.
Scimeca M, Palumbo V, Giacobbi E, Servadei F, Casciardi S, Cornella E, et al.
Heliyon
. 2024 Sep;
10(18):e38047.
PMID: 39328571
Environmental pollution poses a significant threat to human health, particularly concerning its impact on cardiovascular diseases (CVDs). This review synthesizes epidemiological and molecular evidence to elucidate the intricate relationship between...
7.
Martino F, Niglio T, Martino E, Barilla F, Guardamagna O, Paravati V, et al.
Eur J Pediatr
. 2024 Aug;
183(11):4747-4754.
PMID: 39207459
Background And Aims: Cardiovascular diseases (CVD) risk factors include high cholesterol. Children with total cholesterol (TC) levels ≥ 170 mg/dL are usually considered hypercholesterolemic. This study aimed at investigating the...
8.
Filardi P, Nardi E, Agostoni P, Barilla F, Calabro P, Ciccone M, et al.
G Ital Cardiol (Rome)
. 2024 Jun;
25(7):530-540.
PMID: 38916469
Cardiovascular (CV) diseases account for over 4 million deaths every year in Europe and over 220 000 deaths in Italy, representing the leading cause of morbidity and mortality worldwide. The...
9.
Pastore M, Cavigli L, Olivoni G, Morrone F, Amati F, Imbalzano E, et al.
Int J Cardiol
. 2024 Jun;
410:132232.
PMID: 38844090
Arterial hypertension (AH) is one of the most common pathologic conditions and uncontrolled AH is a leading risk factor for cardiovascular disease and mortality. AH chronically causes myocardial and arterial...
10.
Avesani M, Calcaterra G, Sabatino J, Pelaia G, Cattapan I, Barilla F, et al.
Children (Basel)
. 2024 May;
11(5).
PMID: 38790513
Systemic hypertension has been considered mainly as an adult health issue for a long time, but it is now being increasingly acknowledged as a significant problem also among pediatric patients....